These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

974 related articles for article (PubMed ID: 28766057)

  • 1. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.
    Lopes MBS
    Acta Neuropathol; 2017 Oct; 134(4):521-535. PubMed ID: 28821944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the 2022 WHO Classification of Pituitary Tumors.
    Asa SL; Mete O; Perry A; Osamura RY
    Endocr Pathol; 2022 Mar; 33(1):6-26. PubMed ID: 35291028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer Concepts in the Classification of Pituitary Adenomas.
    Sathyakumar R; Chacko G
    Neurol India; 2020; 68(Supplement):S7-S12. PubMed ID: 32611886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors.
    Shibuya M
    Brain Tumor Pathol; 2018 Apr; 35(2):62-70. PubMed ID: 29500747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors.
    Nishioka H; Inoshita N
    Brain Tumor Pathol; 2018 Apr; 35(2):57-61. PubMed ID: 29318396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2017 WHO classification of pituitary adenoma: overview and comments.
    Inoshita N; Nishioka H
    Brain Tumor Pathol; 2018 Apr; 35(2):51-56. PubMed ID: 29687298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological features of pituitary adenomas and sellar region masses.
    Kleinschmidt-DeMasters BK
    Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):476-484. PubMed ID: 27763894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
    Saeger W; Koch A
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Ozganization 2017 Classification of Pituitary Tumors.
    Lopes MBS
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):375-386. PubMed ID: 32741477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification.
    Liu J; He Y; Zhang X; Yan X; Huang Y
    Oncol Lett; 2020 Mar; 19(3):1890-1898. PubMed ID: 32194684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineating the Spectrum of Pituitary Adenoma Based on the WHO 2017 Classification.
    Paramita P; Shilpa R; Nandeesh BN; Yasha TC; Vani S
    Neurol India; 2024 Jan; 72(1):96-101. PubMed ID: 38443009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenomas - practical approach to the diagnosis and the changes in the 2017 WHO classification.
    Rychlý B; Puchertová M; Švajdler M; Zámečník J
    Cesk Patol; 2019; 55(3):137-144. PubMed ID: 31726839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.
    Gomez-Hernandez K; Ezzat S; Asa SL; Mete Ö
    Turk Patoloji Derg; 2015; 31 Suppl 1():4-17. PubMed ID: 26177314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent pituitary plurihormonal adenoma: clinical relevance of immunohistochemical analysis.
    García-Sáenz M; Uribe-Cortés D; González-Virla B; Mendoza-Zubieta V; Vargas-Ortega G
    Rev Med Inst Mex Seguro Soc; 2019 Apr; 57(1):48-55. PubMed ID: 31071255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.